CDER

yellow road to bright light
Biotech

FDA proposes new approval pathway for rare diseases

To be eligible for the process, the investigational drug must take aim at correcting or replacing the specific genetic defect underlying the disease.
Gabrielle Masson Sep 3, 2025 1:20pm
target reach ladder climb meet win beat competition
Favicon Fierce Pharma

FDA taps new CDER chief as acting CBER head after Prasad exit

Jul 30, 2025 1:10pm
FDA
Favicon Fierce Pharma

FDA taps George Tidmarsh to lead CDER

Jul 21, 2025 10:53am
FDA
Favicon Fierce Pharma

FDA's acting CDER head heads for the exit: report

Jun 23, 2025 1:48pm
Delayed on hold

Vanda sues FDA over months-long hearing delay

Apr 23, 2025 10:33am
flat earth

FDA leadership 'decapitated,' former leader Janet Woodcock says

Apr 7, 2025 4:04pm